Explore the potential implications of biologic disease-modifying antirheumatic drug (bDMARD) molecular structure on placental transfer
Professor Robert Landewé is a professor of rheumatology at the Academic Medical Center at the University of Amsterdam, The Netherlands. His research is in the fields of rheumatoid arthritis and spondyloarthritis, with extensive experience in outcome research and clinical trial design and analysis. Professor Landewé is a board member and former President of the Assessment of SpondyloArthritis International Society (ASAS).
The role of combined medical/surgical and medical-only treatments, including the optimal time for intervention
Key guideline updates including management algorithms for inflammatory and non-inflammatory HS phenotypes
Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care
Dr van der Zee and Prof. Arenbergerová explore holistic treatment of HS through medical, surgical and combined approaches
Explore the potential implications of biologic disease-modifying antirheumatic drug (bDMARD) molecular structure on placental transfer
Empower patients with PsA with this interactive guide to help them confidently prepare for appointments and support shared decision-making